A novel lipid formulation containing fenofibrate in omega-3 oil was developed using a novel high-throughput screening platform. The optimized formulation combines the cardiovascular health benefits from omega-3 oil with the potent lipid-regulating effect of fenofibrate. When tested against the current marketed product Tricor in healthy human volunteers, the new formulation was shown to be equivalent to Tricor.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejps.2008.01.005 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!